Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

The clinical effect of probiotic-containing product on health indicators among a population of Central Asia

[thumbnail of Original Article]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
815kB

Item Type:Article
Title:The clinical effect of probiotic-containing product on health indicators among a population of Central Asia
Creators Name:Kushugulova, A.R., Forslund, S.K., Kozhakhmetov, S.S., Kairov, U.E., Molkenov, A.B., Sergazy, S.D., Saduakhassova, S.A., Urazbayeva, G.S., Beysembayeva, S.C., Karabaeva, R.Z., Bakenova, R.A., Nurgozhin, T.S., Benberin, V.V., Zhumadilov, Z.S. and Bork, P.
Abstract:INTRODUCTION: The main goal is to test the efficacy of a synbiotic product which consists of the selected probiotic strains (Lactobacillus plantarum, Lactobacillus fermentum, Lactobacillus acidophilus, Bifidobacterium longum, Bifidobacterium bifidum), inulin, pectin, and fish collagen in adults diagnosed with metabolic syndrome. MATERIALS AND METHODS: This double-blind placebo-controlled trial was conducted among 180 participants aged 25 to 75 years. Subjects with and without metabolic syndrome were randomly assigned to receive synbiotic or placebo daily for three months. 134 of 180 participants completed the study. RESULTS: Compared with the placebo group, the synbiotic group had significantly decreased total cholesterol (TC) from 5.16±0.95 to 4.86±0.86 mmol/L, due to lowering the levels of LDL and triglyceride (p <0.0005). The present findings suggest positive influence of the tested synbiotic on controlling excess weight and in treating some metabolic disorders in adults. CONCLUSION: We conclude that the presented synbiotic formulation here has potential within efforts to reduce the risk and progression of the metabolic syndrome. This trial suggests beneficial effects of a synbiotic supplement for controlling excess weight, as well as the progression of some metabolic disorders, as determined from circulating levels of risk factor biomarkers among adults.
Keywords:Synbiotic, Metabolic Syndrome, Lipid Profile
Source:Science & Healthcare
ISSN:2410-4280
Publisher:Semey Medical University
Volume:22
Number:2
Page Range:49-60
Date:30 April 2020
Official Publication:https://doi.org/10.34689/SH.2020.22.2.005

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library